David J. Bearss
Tracked across 1 events · 7 articles · First seen Jun 15, 2026 · Last active Jun 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: David J. Bearss, CEO of Halia Therapeutics, commented on the significance of the Fast Track designation for the company and patients.
Jun 15, 2026 · 7 articles
ERGEN INTELLIGENCE
Track David J. Bearss live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard